101 related articles for article (PubMed ID: 15152605)
1. Methylation assay by nucleotide incorporation: a quantitative assay for regional CpG methylation density.
Yamamoto T; Nagasaka T; Notohara K; Sasamoto H; Murakami J; Tanaka N; Matsubara N
Biotechniques; 2004 May; 36(5):846-50, 852, 854. PubMed ID: 15152605
[TBL] [Abstract][Full Text] [Related]
2. Monitoring methylation changes in cancer.
Beier V; Mund C; Hoheisel JD
Adv Biochem Eng Biotechnol; 2007; 104():1-11. PubMed ID: 17290816
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence polarization-based method with bisulfite conversion-specific one-label extension for quantification of single CpG dinucleotide methylation.
Li S; Wang Z; Zhou L; Luo F; Zhao C
Genome; 2015 Jul; 58(7):357-63. PubMed ID: 26334496
[TBL] [Abstract][Full Text] [Related]
4. Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.
Bacolod MD; Mirza AH; Huang J; Giardina SF; Feinberg PB; Soper SA; Barany F
J Mol Diagn; 2020 Jul; 22(7):885-900. PubMed ID: 32407802
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.
Galm O; Rountree MR; Bachman KE; Jair KW; Baylin SB; Herman JG
Genome Res; 2002 Jan; 12(1):153-7. PubMed ID: 11779840
[TBL] [Abstract][Full Text] [Related]
6. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
7. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
[TBL] [Abstract][Full Text] [Related]
8. Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene.
Qian XC; Brent TP
Cancer Res; 1997 Sep; 57(17):3672-7. PubMed ID: 9288770
[TBL] [Abstract][Full Text] [Related]
9. Methodological aspects of whole-genome bisulfite sequencing analysis.
Adusumalli S; Mohd Omar MF; Soong R; Benoukraf T
Brief Bioinform; 2015 May; 16(3):369-79. PubMed ID: 24867940
[TBL] [Abstract][Full Text] [Related]
10. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction.
Carless MA
Methods Mol Biol; 2015; 1288():193-212. PubMed ID: 25827881
[TBL] [Abstract][Full Text] [Related]
11. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
13. Evidence for non-CpG methylation in mammals.
Yan J; Zierath JR; Barrès R
Exp Cell Res; 2011 Nov; 317(18):2555-61. PubMed ID: 21925168
[TBL] [Abstract][Full Text] [Related]
14. Predicting methylation status of CpG islands in the human brain.
Fang F; Fan S; Zhang X; Zhang MQ
Bioinformatics; 2006 Sep; 22(18):2204-9. PubMed ID: 16837523
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
[TBL] [Abstract][Full Text] [Related]
16. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
Gitan RS; Shi H; Chen CM; Yan PS; Huang TH
Genome Res; 2002 Jan; 12(1):158-64. PubMed ID: 11779841
[TBL] [Abstract][Full Text] [Related]
17. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
18. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
[TBL] [Abstract][Full Text] [Related]
20. Estimating the total mouse DNA methylation according to the B1 repetitive elements.
Jeong KS; Lee S
Biochem Biophys Res Commun; 2005 Oct; 335(4):1211-6. PubMed ID: 16115613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
